Alk-Abello AS (AKBLF)
22.05
0.00 (0.00%)
USD |
OTCM |
Nov 21, 16:00
Alk-Abello Max Drawdown (5Y): 66.02% for Sept. 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2024 | 66.02% |
| August 31, 2024 | 66.02% |
| July 31, 2024 | 66.02% |
| June 30, 2024 | 66.02% |
| May 31, 2024 | 66.02% |
| April 30, 2024 | 66.02% |
| March 31, 2024 | 66.02% |
| February 29, 2024 | 66.02% |
| January 31, 2024 | 66.02% |
| December 31, 2023 | 66.02% |
| November 30, 2023 | 66.02% |
| October 31, 2023 | 66.02% |
| September 30, 2023 | 66.02% |
| August 31, 2023 | 66.02% |
| July 31, 2023 | 66.02% |
| June 30, 2023 | 52.89% |
| May 31, 2023 | 52.89% |
| April 30, 2023 | 52.89% |
| March 31, 2023 | 45.31% |
| February 28, 2023 | 45.31% |
| January 31, 2023 | 45.31% |
| December 31, 2022 | 45.31% |
| November 30, 2022 | 45.31% |
| October 31, 2022 | 36.60% |
| September 30, 2022 | 36.60% |
| Date | Value |
|---|---|
| August 31, 2022 | 29.20% |
| July 31, 2022 | 29.20% |
| June 30, 2022 | 29.20% |
| May 31, 2022 | 29.20% |
| April 30, 2022 | 29.20% |
| March 31, 2022 | 29.20% |
| February 28, 2022 | 29.20% |
| January 31, 2022 | 21.88% |
| December 31, 2021 | 20.93% |
| November 30, 2021 | 20.93% |
| October 31, 2021 | 24.00% |
| September 30, 2021 | 28.52% |
| August 31, 2021 | 28.52% |
| July 31, 2021 | 28.52% |
| June 30, 2021 | 28.52% |
| May 31, 2021 | 28.52% |
| April 30, 2021 | 28.52% |
| March 31, 2021 | 28.52% |
| February 28, 2021 | 28.52% |
| January 31, 2021 | 28.52% |
| December 31, 2020 | 28.52% |
| November 30, 2020 | 28.52% |
| October 31, 2020 | 28.52% |
| September 30, 2020 | 28.52% |
| August 31, 2020 | 28.52% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
20.93%
Minimum
Nov 2021
66.02%
Maximum
Jul 2023
40.62%
Average
29.20%
Median
Feb 2022
Max Drawdown (5Y) Benchmarks
| Genmab AS | 54.19% |
| Ascendis Pharma AS | 61.72% |
| Galecto Inc | -- |
| Evaxion Biotech AS | -- |
| IO Biotech Inc | -- |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | 12.55 |
| Beta (5Y) | 0.3075 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 45.70% |
| Historical Sharpe Ratio (5Y) | 0.3666 |
| Historical Sortino (5Y) | 0.7314 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 14.71% |